Assessing outcome measures of oral anticoagulation management in children

Thrombosis Research

Volumn 127, Issue 2, 2011, Pages 75-80

  Jones, Sophie ^b   Newall, Fiona ^a,b,c   Manias, Elizabeth ^b   Monagle, Paul ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Adverse events; Children; Oral anticoagulation therapy; Quality of life; Time in therapeutic range

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; CHILD; DEEP VEIN THROMBOSIS; DRUG FATALITY; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; MENORRHAGIA; MUCOCUTANEOUS LYMPH NODE SYNDROME; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SUBDURAL HEMATOMA; THROMBOEMBOLISM; THROMBOSIS; THROMBUS; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; ADOLESCENT; ANTICOAGULANTS; CHILD; HUMANS; TREATMENT OUTCOME;

EID: 79151483048     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.09.001     Document Type: Review

References (57)

1. H. Desai, and E. Farrington Anticoagulation with warfarin in pediatrics Pediatr Nurs 26 2 2000 199 203
2. C. van Doorn, R. Yates, A. Tunstill, and M. Elliott Quality of life in children following mitral valve replacement Heart 84 6 2000 643 647
3. P. Monagle, A.D. Michelson, E. Bovill, and M. Andrew Antithrombotic therapy in children Chest 119 2001 344S 370S (supplement)
4. P. Monagle, E.T. Murray, K.M. Gee, T.F. Allan, F.D. Hobbs, and F.D.R. Hobbs Andrew sPediatric Thromboembolism and Stroke 3rd edition 2006 BC Decker Inc. Hamilton, Canada
5. M.E. Bauman, K. Black, S. Kuhle, L. Wang, L. Legge, and D. Callen-Wicks KIDCLOT: the importance of validated educational intervention for optimal long term warfarin management in children Thromb Res 123 5 2009 707 709
6. M.J. Bradbury, G. Taylor, P. Short, and M.D. Williams A comparative study of anticoagulant control in patients on long-term warfarin using home and hospital monitoring of the international normalised ratio Arch Dis Child 93 4 2008 303 306
7. T.D. Christensen, N.T. Andersen, J. Attermann, V.E. Hjortdal, M. Maegaard, and J.M. Hasenkam Mechanical heart valve patients can manage oral anticoagulant therapy themselves Eur J Cardiothorac Surg 23 2003 292 298
8. T.D. Christensen, N.T. Andersen, M. Maegaard, O.K. Hansen, V.E. Hjortdal, and J.M. Hasenkam Oral anticoagulation therapy in children: successfully controlled by self-management Heart Surg Forum 7 4 2004 E321 E325
9. T.D. Christensen, J. Attermann, V.E. Hjortdal, M. Maegaard, and J.M. Hasenkam Self-management of oral anticoagulation in children with congenital heart disease Cardiol Young 11 2001 269 276
10. S. Mahonen, P Riikonen, R.L. Vaatainen, and T. Tikanoja Oral anticoagulant treatment in children based on monitoring at home Acta Paediatr 93 5 2004 687 691
11. P. Massicotte, V. Marzinotto, P. Vegh, M. Adams, and M. Andrew Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor J Pediatr 127 3 1995 389 394
12. F. Newall, P. Monagle, and L. Johnston Home INR monitoring of oral anticoagulant therapy in children using CoaguChek S point-of-care monitor and a robust education program Thromb Res 118 2006 587 593
13. F. Newall, H. Savoia, J. Campbell, and P. Monagle Anticoagulation clinics for children achieve improved warfarin management Thromb Res 114 2004 5 9
14. W. Streif, M. Andrew, V. Marzinotto, M.P. Massicotte, A. Chan, and J.A. Julian Analysis of Warfarin therapy in pediatric patients: a prospective cohort study of 319 patients Blood 94 1999 3007 3014
15. D. Fitzmaurice, D. Fitzmaurice, E. Murray, D. McCahon, R. Holder, J. Raftery, and S. Hussain Self management of oral anticoagulation: Randomised trial BMJ 2005 331
16. J. Ansell, J. Hirsch, E. Hylek, A. Jacobson, M. Crowther, and G. Palareti Pharmacology and management of the Vitamin K anatgonists, American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th edition) Chest 133 6-supplement 2008 160s 198s
17. M.N. Levine, G. Raskob, R.J. Beyth, C. Kearon, and S. Schulman Hemorrhagic Complications of Anticoagulant Treatment Chest 126 3 suppl 2004 287S 310S
18. M. Andrew, V. Marzinotto, L.A. Brooker, M. Adams, J. Ginsberg, and R. Freedom Oral anticoagulation therapy in pediatric patients: a prospective study Thromb Haemost 71 3 1994 265 269
19. M. Andrew Indications and drugs for anticoagulation therapy in children Thromb Res 81 2, Supplement 1 1996 S61 S73
20. P. Monagle Thrombosis in pediatric cardiac patients. (Hide details) Semin Thromb Hemost 29 6 2003 547 555
21. P. Monagle Anticoagulation in the young Heart 90 7 2004 808 812
22. P. Monagle, E. Chalmers, A. Chan, G. de Veber, F. Kirkham, and M.P. Massicotte Antithrombotic Therapy in Neonates and Children in the American College of Chest Physicians Evidence-based Practice Guidelines (8TH Edition) Chest 133 6 2008 887S 968S
23. P. Monagle, A. Cochrane, B. McCrindle, L. Benson, W. Williams, and M. Andrew Editorial: Thromboembolic Complications After Fontan Procedures-The Role Of Prophylactic Anticoagulation J Thorac Cardiovasc Surg 115 3 1998 493 498
24. G. Palareti Warfarin anticoagulation in children made easier Thromb Res 118 2006 667 669
25. F. Newall, and M. Bauman Point-of-care antithrombotic monitoring in children Thromb Res 118 1 2006 113 121
26. M.J. Manco-Johnson, R. Nuss, T. Hays, W. Krupski, J. Drose, and M.L. Manco-Johnson Combined thrombolytic and anticoagulant therapy for venous thrombosis in children.[see comment] J Pediatr 136 4 2000 446 453
27. N. Reiss, U. Blanz, H. Bairaktaris, A. Koertke, and R. Korfer Mechanical valve replacement in congenital heart defects in the era of International Normalised Ratio self-management Am Soc Artif Intern Organs 2005 530 532
28. T.D. Christensen Self-management of oral coagulant therapy: a review J Thromb Thrombolysis 18 2 2004 127 143
29. R.C. Tait, E.J. Ladusans, M. El-Metaal, R.G. Patel, and A.M. Will Oral anticoagulation in paediatric patients: dose requirements and complications Arch Dis Child 74 1996 228 231
30. K. Suda, Y. Kudo, T. Higaki, Y. Nomura, M. Miura, and M. Matsumura Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease Circ J 73 7 2009 1319 1323
31. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 4 2005 692 694
32. V. Marzinotto, P. Monagle, A. Chan, M. Adams, M.P. Massicotte, and M. Leaker Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting Pediatr Cardiol 21 2000 347 352
33. F. Newall, L. Johnston, and P. Monagle Optimising anticoagulant education in the paediatric setting using a validated model of education Patient Educ Couns 73 2 2008 384 388
34. A. Greenway, V. Ignjatovic, R. Summerhayes, F. Newall, J. Burgess, and L DeRosa Point-of-care monitoring of oral anticoagulation therapy in children - Comparison of the CoaguChek XS® system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95) Thromb Haemost 102 1 2009 159 165
35. F. Newall, and P. Monagle Oral anticoagulant thromboprophylaxis for Kawasaki disease.(Letter to the Editor) Pediatr Cardiol 27 2 2006 301 (1)
36. S. Schulman, R.J. Beyth, C. Kearon, and M.N. Levine Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 2008 257S 298S (Supplement)
37. D.A. Fitzmaurice A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management J Clin Pathol 55 11 2002 845 849
38. A.P. Gadisseur, A.A. Kaptein, W.G. Breukink-Engbers, F.J. van der Meer, and F.R. Rosendaal Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life J Thromb Haemost 2 4 2004 584 591
39. J.A. Sloan, M.Y. Halyard, M.H. Frost, A.C. Dueck, B. Teschendorf, and M.L. Rothman The Mayo Clinic Manuscript Series Relative to the Discussion, Dissemination, and Operationalization of the Food and Drug Administration Guidance on Patient-Reported Outcomes Value Health 10 2007 S59 S63
40. P.T. Sawicki A structured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial JAMA 281 2 1999 145 150
41. D.T. Yang, R.S. Robetorye, and G.M. Rodgers Home prothrombin time monitoring: a literature analysis Am J Hematol 77 2 2004 177 186
42. C. Eiser No pain, no gain? Integrating QoL assessment in paediatrics Arch Dis Child 92 5 2007 379 380
43. C. Eiser Use of quality of life measures in clinical trials Ambul Pediatr 4 2004 395 399
44. E. Sabate E. Sabate, Adherence to long-term therapies: evidence for action 2003 World Health Organisation 209
45. FDA, Guidance for Industry: Patient-reported outcome measures: Use in medical product development to support labeling claims, F.a.D. Authority, Editor. 2006.
46. A.L. Quittner, M. Avani, and C. Ivette Systematic review of health-related quality of life measures for children with respiratory conditions Paediatr Respir Rev 9 3 2008 220 232
47. R.M. Taylor, F. Gibson, and L.S. Franck A concept analysis of health-related quality of life in young people with chronic illness J Clin Nurs 17 2008 1823 1833
48. F.A. Casey, B.G. Craig, and H.C. Mulholland Quality of life in surgically palliated complex congenital heart disease Arch Dis Child 70 5 1994 382 386
49. S.A. Clarke, and C. Eiser The measurement of health-related quality of life in pediatric clinical trials: A systematic review Health Qual Life Outcomes 2 66 2004 1 5
50. Bruce, A.A.K.; Bauman ME, Black K, Newton A, Legge L, Massicotte MP. Development and preliminary evaluation of the KIDCLOT PAC QL©: A new health-related quality of life measure for pediatric long-term anticoagulation therapy. Thromb Res 2010;126(2):e116-21.
51. D.I.K. Evans, M. Rowlands, and L. Poller Survey of oral anticoagulant treatment in children J Clin Pathol 45 1992 707 708
52. Y. Sugahara, M. Ishii, H. Muta, M. Iemura, T. Matsuishi, and H. Kato Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease Pediatr Cardiol 29 2 2008 398 401
53. F. Newall, P. Monagle, and L. Johnston Patient understanding of warfarin therapy: A review of education strategies Hematology 10 6 2005 437 442
54. M.E. Bauman, K.L. Black, M.P. Massicotte, M.L. Bauman, S. Kuhle, and S. Howlett-Clyne Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin Thromb Haemost 99 2008 1097 1103
55. J. Hill, S. Perreault, and M. Dorval Validity of CoaguChek S for home monitoring of anticoagulant therapy in pediatrics Can J Cardiol 23 1 2007 47 50
56. V. Ignjatovic, C. Barnes, F. Newall, S. Hamilton, J. Burgess, and P. Monagle Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio Thromb Haemost 92 2004 734 737
57. V.K. Williams, and A.B.M. Griffiths Acceptability of CoaguChek S and CoaguChek XS generated international normalised ratios against a laboratory standard in a paediatric setting.[see comment] Pathology 39 6 2007 575 579